Patents by Inventor Ankit Baheti

Ankit Baheti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20240016732
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: January 27, 2023
    Publication date: January 18, 2024
    Applicant: Scilex Holding Company
    Inventors: Sagar Munjal, Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • EXTENDED RELEASE COMPOSITION OF TOFACITINIB
    Publication number: 20220249385
    Abstract: The present disclosure provides an extended release composition of tofacitinib for oral administration, and methods of making the composition. The extended release composition employs a matrix drug core comprising tofacitinib or a pharmaceutically acceptable salt thereof and at least one release controlling polymer. The matrix drug core is surrounded by a soluble functional coating comprising at least one coating polymer and at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: March 4, 2020
    Publication date: August 11, 2022
    Applicant: Unichem Laboratories Limited
    Inventors: Dhananjay SATHE, Bijay PADHI, Ankit BAHETI, Sachin BALI
  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20220241298
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: September 10, 2021
    Publication date: August 4, 2022
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • MODIFIED RELEASE DOXYCYCLINE COMPOSITION
    Publication number: 20220031714
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Application
    Filed: February 19, 2021
    Publication date: February 3, 2022
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • Modified release doxycycline composition
    Patent number: 10953022
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: March 23, 2021
    Assignee: GALDERMA HOLDING SA
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20200352853
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 12, 2020
    Inventors: Sagar MUNJAL, Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Oral composition of celecoxib for treatment of pain
    Patent number: 10799517
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: October 13, 2020
    Assignee: DR. REDDY'S LABORATORIES LTD
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Oral composition of celecoxib for treatment of pain
    Patent number: 10722456
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: July 28, 2020
    Assignee: DR. REDDY'S LABORATORIES LTD
    Inventors: Sagar Munjal, Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • MODIFIED RELEASE DOXYCYCLINE COMPOSITION
    Publication number: 20200078378
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Application
    Filed: April 18, 2019
    Publication date: March 12, 2020
    Applicant: Nestle Skin Health SA
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • Oral composition of celecoxib for treatment of pain
    Patent number: 10376527
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: August 13, 2019
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20190224219
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: March 29, 2019
    Publication date: July 25, 2019
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Modified release doxycycline composition
    Patent number: 10300081
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: May 28, 2019
    Assignee: NESTLE SKIN HEALTH SA
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20180200271
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: March 15, 2018
    Publication date: July 19, 2018
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • MODIFIED RELEASE DOXYCYCLINE COMPOSITION
    Publication number: 20180200272
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Application
    Filed: January 19, 2018
    Publication date: July 19, 2018
    Applicant: Nestle Skin Health SA
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20180200270
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: March 15, 2018
    Publication date: July 19, 2018
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Oral composition of celecoxib for treatment of pain
    Patent number: 9949990
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: April 24, 2018
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Modified release doxycycline composition
    Patent number: 9901588
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: February 27, 2018
    Assignee: Nestlé Skin Health SA
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20180008619
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: September 22, 2017
    Publication date: January 11, 2018
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN
    Publication number: 20170340561
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Inventors: Sagar MUNJAL, Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Oral composition of celecoxib for treatment of pain
    Patent number: 9795620
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: October 24, 2017
    Assignee: Dr. Reddy's Laboratories, Ltd.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi